GB Group Ord Shs GBGPF

Why the sudden volume and price increase?

[Duediligence33]

I am a WEED long holder but there is a fascination with the very small market cap of CMED 300 million versus 2 billion for WEED and both at around $ 12 Why the sudden volume today and what will the earnings be hoped for on Feb 23 I know CMED is very well respected for the medical quality and reliability of med Cannabis but Brent Zettl has maintained no interest in the recreational Cannabis market so there is a niche for CMED but Weed does have Bedrocan for the strickly serious Medical market Nevertheless I will buy some CMED as a hedge in case there is a delay in the recreation rollout and slow down the leader Canopy I will do some DD and report back

[DanielBoone733]

Check a quote by Zettl himself from this interview on Jan 24th.  https://www.midasletter.com/2017/01/cannimed-therapeutics-inc-ceo-brent-zettl-on-the-cannabis-evolution-of-prairie-plant-systems/ James West:    Okay. So it sounds like to me that CanniMed is very much focused on the medical applications for cannabis exclusively. And are you positioning or anticipating

[DanielBoone733]

CMED will 100 percent take advantage of the rec market but they are being smart. They are maintaining their status as the most respected medical producer first while the market is current and guaranteed.  As recreational use is legalized CMED can utilize their massive grow space or else expand further and easily be ready for day one of legalization.  And yes that low market cap is sexy

[LettinPoniesRun]

GMP certification is going to go a long way in distinquishing CMED from their peers long term. If Institutions start to pour in this will prove to be a valuable asset.